Method for identifying risk of melanoma and treatments thereof
CA 2504903 A1 · Owner: Nelson, Matthew Roberts · Inventors: Roth, Richard B.; Nelson, Matthew Roberts; Braun, Andreas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more CDK10 FPGT, PCLO or , REPS2 directed agents. These embodiments are based upon an analysis of polymorphic variations in a CDK10, FPGT PCLO or REPS2 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1 2, 3 or 4.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.